P773: CYCLOPHOSPHAMIDE COMBINED WITH PREDNISONE FOR CYCLOSPORINE-REFRACTORY/RELAPSED T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA ASSOCIATED PURE RED CELL APLASIA

P773: CYCLOPHOSPHAMIDE COMBINED WITH PREDNISONE FOR CYCLOSPORINE-REFRACTORY/RELAPSED T-LARGE GRANULAR LYMPHOCYTE LEUKEMIA ASSOCIATED PURE RED CELL APLASIA

Bibliographic Details
Main Authors:	Xiaoqing Liu, Yue LI, Yuemin Gong, Yawen Zhang, Xinyu Zhang, Qiqiang Long, Guangsheng He, Jianyong LI
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000969996.50238.ad

Similar Items

Acquired pure megakaryocytic aplasia successfully treated with cyclosporine
by: Halima El Omri, et al.
Published: (2010-12-01)

Acquired pure megakaryocytic aplasia successfully treated with cyclosporine
by: Halima El Omri, et al.
Published: (2010-12-01)

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications
by: Haotian Shi, et al.
Published: (2023-05-01)

Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone
by: Yixin Hu, et al.
Published: (2012-01-01)

P1133: CHIDAMIDE PLUS PREDNISONE, CYCLOPHOSPHAMIDE, AND THALIDOMIDE (CPCT) FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER PHASE II TRIAL
by: Jinhua Liang, et al.
Published: (2023-08-01)

PB2048: HEMATOLOGIC RECOVERY INDUCED BY AVATROMBOPAG IN SAA REFRACTORY OR INTOLERANT TO IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG
by: Xiaoqing Liu, et al.
Published: (2023-08-01)

Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study
by: Yuan Yang, et al.
Published: (2023-05-01)

Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone
by: Wenqian Wang, et al.
Published: (2024-01-01)

Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma
by: Troy J. Kenkel, et al.
Published: (2023-10-01)

PB2049: THE EFFICACY OF HETROMBOPAG PLUS CYCLOSPORINE A IN PATIENTS WITH TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY
by: Yuemin Gong, et al.
Published: (2023-08-01)

PB2034: TARGETED SEQUENCING LANDSCAPE OF A CHINESE PURE RED CELL ANEMIA COHORT
by: Yue LI, et al.
Published: (2023-08-01)

P763: EFFICACY AND SAFETY OF AVATROMBOPAG IN THE TREATMENT OF TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
by: Ting Zhang, et al.
Published: (2023-08-01)

PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN
by: MIhajlovic Filip, et al.
Published: (2018-05-01)

Erythropoietin‐induced pure red cell aplasia
by: Vivian K. P. Yeung
Published: (2022-08-01)

Lenalidomide-Induced Pure Red Cell Aplasia
by: Tuphan Kanti Dolai, et al.
Published: (2014-02-01)

RIFAMPICIN INDUCED PURE RED CELL APLASIA
by: Marija Čeh
Published: (2008-04-01)

Acquired pure red cell aplasia: unraveling the immune pathogenesis
by: Mengyuan Liu, et al.
Published: (2023-12-01)

Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma
by: Ke Lian, et al.
Published: (2023-05-01)

Pure Red Blood Cell Aplasia and Isoniazid Use
by: Pierre Loulergue, et al.
Published: (2007-09-01)

P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
by: Swetha Kambhampati, et al.
Published: (2022-10-01)

Invasive thymoma with pure red cell aplasia and amegakaryocytic thrombocytopenia
by: Takuya Onuki, et al.
Published: (2016-12-01)

THE PURE RED BLOOD CELL APLASIA IN RENAL TRANSPLANT RECIPIENT
by: B. T. Dzumabaeva, et al.
Published: (2011-06-01)

Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3
by: Sooyong Park, et al.
Published: (2023-05-01)

UMP bakal rai 2,773 graduan
by: Siti Nur Azwin, Zulkapri
Published: (2018)

2,773 terima ijazah teknologi Blockchain
by: Siti Nur Azwin, Zulkapri
Published: (2018)

Characteristics of Unintentional Injuries in 15 773 Children
by: SHEN Yu, CHEN Jian, SHOU Tiejun, YU Beirong
Published: (2023-09-01)

Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia
by: Seema Naik, et al.
Published: (2024-01-01)

Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results
by: Holger W. Auner, et al.
Published: (2022-04-01)

Effects of cyclosporine on steroid-refractory dry eyes
by: Wan-Lin Wu, et al.
Published: (2023-01-01)

Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia
by: Destini Teague, et al.
Published: (2022-12-01)

Pure red cell aplasia and seronegative myasthenia gravis in association with thymoma
by: Sun Yong Lee, et al.
Published: (2020-05-01)

Linezolid-Induced Pure Red Cell Aplasia: A Case Report
by: Yang XY, et al.
Published: (2022-07-01)

A case series of emtricitabine-induced pure red cell aplasia
by: Nithendra Manickchund, et al.
Published: (2021-08-01)

A pregnant woman with thymoma-associated pure red cell aplasia
by: Megumi Shibata, et al.
Published: (2022-10-01)

Research progress on antibody-mediated pure red cell aplasia in chronic kidney disease
by: You Xiaoe, Ma Hualin, Wang Zhen, Zhang Xinzhou, Guo Baochun
Published: (2023-06-01)

Results of Vincristine, Cyclophosphamide and Topotecan Protocol in Refractory/Relapsed Pediatric Solid Tumors: A Single-center Experience
by: Uğur Demirsoy, et al.
Published: (2019-09-01)

Treatment for acquired aplasia and refractory cytopenia. Review of a historical cohort
by: Jesús González de Pablo, et al.
Published: (2022-10-01)

P790: DISTINCT MUTATIONAL PATTERN OF T-CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA COMBINED WITH PURE RED CELL APLASIA: LOW MUTATIONAL BURDEN OF STAT3
by: Sooyong Park, et al.
Published: (2023-08-01)

Idiopathic pure red cell aplasia: A case series from India
by: Manoj U Mahajan, et al.
Published: (2023-05-01)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
by: Maryam Rahbar, et al.
Published: (2017-01-01)